Saskatchewan saw a spike in new COVID-19 cases on Thursday, reporting 334.
The province’s seven-day average of daily new cases is now 254 — or 20.9 new cases per 100,000 population.
It was at 153 just eight days ago on Dec. 30.
Three more seniors have died in Saskatchewan after being diagnosed with COVID-19. This brings the province’s COVID-related death toll to 177.
One of the newly reported deaths was in the 70 to 79 age group in the Regina zone. Two people were in the 80 and older age group, one in the north central and one in the Regina zone.
The Saskatoon area is the hotspot with 83 new cases and the north central zone is close behind with 65.
Of the remaining new cases, 15 are located in the far northwest, one is in the far north central, 24 are in the far northeast, 11 are in the northwest, 14 are in the northeast, four are in the central west, six are in the central east, 49 are in the Regina area, one is in the southwest, one is in the south central and 33 are in the southeast zones.
Twenty-seven of the new cases have pending residence information.
Of the provinces total 17,138 COVID-19 cases, 2,947 cases are considered active. There have been 278 new recoveries.
One hundred and seventy-six people are in hospital, 147 of whom are receiving in-patient care. One is in the far north central, one is in the far northeast, eight are in the northwest, 31 are in the north central, three are in the northeast, 39 are in the Saskatoon area, seven are in the central east, 45 are in the Regina area, two are in the south central and 10 are in the southeast.
Twenty-nine people are in intensive care, with two in the northwest, five in the north central, nine in the Saskatoon area and 12 in the Regina zone.
Immunizations for eligible health-care staff, along with long term and personal care home residents, began this morning in Prince Albert, which has now received 3,900 Pfizer-BioNtech vaccine doses.
As of Thursday, a total of 4,832 doses of COVID-19 vaccine have been administered in Saskatchewan, including 2,069 Pfizer-BioNtech doses in the Regina pilot program and 233 second doses, 2,407 Pfizer doses in Saskatoon, and 123 Moderna doses in the far northwest zone.
An additional 100 Moderna doses have been allocated to Saskatchewan. This increases the Feb. 1 expected vaccine delivery to 5,400 doses.
The province says February allocations for the Pfizer-BioNtech vaccine have been confirmed — 11,700 doses will be arriving each week.
CBC Saskatchewan wants to hear how the COVID-19 pandemic has impacted you. Share your story with our online questionnaire.
COVID-19 changed how we work. Will it stick? – CBC.ca
How we work was heating up to be an important debate long before the pandemic added rocket fuel to remote working capacity. Now, millions of people have spent the past 10 months in a pandemic-imposed trial. They have set up a corner of their home as an all-in-one office, school and living area.
Some love it. Pat Suwalski does not.
Suwalski is part of a historic shift in the job market. At the peak of the pandemic lockdowns in April, more than 40 per cent of those still working at least half their usual hours were working from home, according to Statistics Canada.
That number declined to around 26 per cent in September 2020 before “increasingly slightly in the fall,” the agency said.
“In three industries — professional, scientific and technical services; finance, insurance, real estate, rental and leasing; and public administration — working from home has remained at elevated levels,” it said.
In areas such as education, which was affected by school shutdowns and the shift to remote learning early in the pandemic, only about a third of people were working from home by December compared to close to half in April.
The question among experts, economists and business owners is how many of them will return to their workplaces when the crisis is over.
“I’m pretty enthusiastic to get back to the office whenever it’s possible to do so,” said Suwalski, a developer for a small software firm called Vectorface in Ottawa.
Suwalski usually shares an office with 15 co-workers. Now, he shares a room with his son Jacob who’s on a Zoom call with his kindergarten class. Meanwhile, his three-year-old daughter is at daycare.
Suwalski misses in-person meetings. He misses impromptu hangouts in the hallways. He even misses his commute.
“I’m in a car by myself,” he said. “I can either listen to the radio or focus on my thoughts.”
Suwalski thinks others will also want to return to their offices.
“I think, at best, we’re going to go back to a partial in-office presence and then work from home as well,” he said.
Demand for flexibility
It’s not just employees pondering a return to the office.
Margaret Szots, a talent development manager with the City of Toronto, is also trying to figure out what the future will look like.
She was working on a way to give employees more flexibility before COVID-19 hit.
“We know what many of the issues are because we’re living them,” she said.
The benefits are clear — people don’t have to commute, they’re saving money and they’re saving time, she said.
However, the long-term impact remains mired in uncertainty, she said.
“We were already on a trajectory to this new way of working,” she said. “[The pandemic] pushed us that much more quickly … We’re not going back to the way we were.”
San Diego-based Kate Lister, president of the Global Workplace Analytics consulting firm, predicted the pandemic would be “the tipping point for remote work.”
Early in the pandemic, she estimated, “25 to 30 per cent of the workforce would work from home multiple days a week when the threat was over.”
“It felt like a bold assertion. Now, nearly nine months into the world’s largest work-from-home experiment, if anything, I’m feeling my estimate might be low,” she writes in a January 2021 report on remote work.
For employers, remote work has offered benefits such as reduced eal estate costs, less absenteeism, lower employee turnover and increased productivity, the report found.
Companies big and small are looking at their workforces now and trying to figure out how things will look in six months or a year.
Facebook said as many as half of its employees will work remotely for the foreseeable future.
In a virtual town hall meeting with employees in May, CEO Mark Zuckerberg said that doesn’t mean employees have permission to decamp to their hometowns or a beach somewhere.
“Your salary will be adjusted if you change location,” he said, noting that’s a long-standing policy.
But people who want to work remotely won’t be the challenge, he said.
“It’s going to be that there are more people who want to get back into the office than we can support,” he said.
Avery Shenfeld, CIBC’s chief economist in Toronto, agreed.
People have had ample opportunity to work from home for years, and Zoom has been around since 2013, he said.
“I keep hearing all these people [saying]: ‘We’re all going to work from home forever,'” he said. “No [we won’t] because it’s not effective.”
At least it’s not effective for everyone.
But that’s not to say there will be a flood of people rushing back to their offices next spring or summer.
Even once restrictions loosen, it’s not like giant office towers can just open the doors and let everyone back in.
“I don’t think there will be a single moment when this COVID period is done,” Zuckerberg said back in the spring, and the pandemic has only worsened since then.
Some health and safety restrictions will remain in place even as other broader restrictions are lifted.
Getting everyone to stay home was relatively simple. Finding a way to get them back to the office will be a much more complicated affair.
Vaccine manufacturers concerned about provinces delaying second doses: Anand – CTV News
While Canada’s top immunization experts have signed off on provinces delaying the administration of the second Pfizer and Moderna doses in an effort to begin vaccinating more people with a small supply, Procurement Minister Anita Anand says she’s heard concerns from the manufacturers that may impact future deliveries.
In an interview on CTV’s Question Period airing on Sunday, Anand said that some drug companies have brought up concerns with Canada or other countries not following the recommended usage protocols set out by the vaccine manufactures, as they are based on data from their clinical trials.
“That has not directly impacted our deliveries to date, but it has been a concern that vaccine corporations have raised with us in our discussions,” Anand said. While she would not say whether a company has outright said it would withhold future doses, she said the issue has come up in negotiations.
“It is still a recommendation from the manufacturers that we are hearing at the table” to follow their protocols, she said.
This week, the National Advisory Committee on Immunization (NACI) approved delaying administering second doses of the Pfizer and Moderna vaccines for up to 42 days. The decision was made in the face of rising cases and strained hospitals.
The two vaccines that have been approved in Canada so far – made by PfizerBioNTech and Moderna — require two separate doses in order to achieve 94-95 per cent immunity for the patient.
These doses are spaced apart. Pfizer’s second dose is intended to be delivered 21 days after the first, while Moderna’s has a 28-day wait in between the doses.
The report from NACI stated that while the ideal is to follow the vaccine manufacturers’ recommendations, people can wait longer — 42 days or so for the second dose — in order to allow double the number of Canadians to get some partial protection by receiving their first shot faster.
However, contrary to NACI’s recommendations, Quebec public health officials have announced they plan to prolong second doses in that province for up to 90 days between the first and second dose, and Ontario indicated on Friday that given the upcoming temporary Pfizer shortage that province may also extend the timeframe between doses.
SOME TRIAL PARTICIPANTS HAD DOSE DELAYS
In a separate interview on CTV’s Question Period, NACI chair Dr. Caroline chair Dr. Caroline Quach-Thanh said that while Pfizer and Moderna have recommended shorter windows between vaccinations, in phase three trials for both vaccines, candidates received their second dose up to 42 days after the first.
“So the actual vaccine efficacy that are reported in those trials are covering a span from 21 to 42 days. It’s impossible to say if people who got their second dose at 42 days are protected better, less, or worse than the ones that got it before,” she said.
She’s suggesting Quebec conduct surveillance to ensure the vaccine remains effective if the second shot is given so late after the first.
“If we had enough doses to vaccinate all the high-risk groups right away with it two doses, we would stick to label. But at one point in time if you have to choose between vaccinating only a small proportion of your population, and let the variant spread very quickly, there’s no health gains here,” she said.
With files from CTV News’ Alexandra Mae Jones, CTV Montreal and CTV Toronto.
Couche-Tard and Carrefour Abandon Takeover Talks – Bloomberg
Canada’s Alimentation Couche-Tard Inc. and Carrefour SA broke off talks on a proposed $20 billion deal in the face of strong opposition from France’s finance minister to the tie-up, according to people familiar with the matter.
The decision to halt negotiations came after top executives of the Quebec-based convenience-store operator flew to Paris to offer the government several sweeteners: billions of euros of investment in Carrefour stores, no job cuts for at least two years and dual stock listings in France and Canada.
It was not enough to persuade Finance Minister Bruno Le Maire, who told executives in a private meeting Friday he was standing by his position that a takeover would be bad for France. Earlier, Le Maire said on BFM TV: “To sum up: it’s a no. A courteous no, but a no that is clear and definitive.”
Couche-Tard executives are flying back to Canada after the failed talks, the people said. While discussions are on ice for now, they could be revived later if the government changes its position, they said.
A merger would have created a retail powerhouse, combining Couche-Tard’s North America-focused network of 14,200 convenience stores with Carrefour’s sizable European operations, which include hypermarkets and smaller outlets. Carrefour has more than 7,000 convenience stores and gets almost all of its revenue from Europe and Latin America.
Couche-Tard, Canada’s largest retailer by market value, faced hurdles from the outset for its offer of 20 euros per share. Le Maire signaled that even if both parties agreed to the transaction, regulators might still block it. Carrefour shares fell 2.9% to 16.61 euros in Paris on Friday. Couche-Tard rose 4.8% to C$37.98 in Toronto.
Representatives from Carrefour and Couche-Tard didn’t respond to requests for comment. The decision to stop negotiations was reported first by Reuters.
For French President Emmanuel Macron, the political stakes are high with local elections later this year and presidential ones in 2022. The campaign is already on, with his handling of the pandemic making him open to criticism. The loss of a well-known French company to a foreign takeover could fuel nationalist Marine Le Pen, his primary rival for leadership.
France has often objected to foreign attempts to take over its blue-chip companies — frowning on talk of an approach from PepsiCo Inc. to yogurt maker Danone SA in 2005, for example.
The bid for Carrefour was especially sensitive because it is France’s largest private employer. On top of that, the pandemic has thrust jobs and the nation’s food supply to the top of the political agenda. “If this deal continues, food sovereignty comes before everything,” Le Maire said earlier this week, citing a decree he introduced in 2019 on state screening of foreign investments.
France isn’t the only country caught in a wave of protectionism that’s been heightened by companies’ suffering due to the coronavirus pandemic. The U.K. late last year drew up plans to give the government sweeping powers to intervene in foreign takeovers of assets deemed a threat to national security.
Some Couche-Tard analysts had questioned the deal’s strategic rationale and said it wouldn’t create significant cost savings as there’s little overlap between the two companies’ store networks. Both retailers’ bonds had slipped on concerns that the deal would swell the combined company’s debt burden.
The brutal ending marks the second time in nine months that Couche-Tard has come close to a major takeover, only to see it fizzle out.
In April, the company cited the pandemic as a reason for walking away from a $5.6 billion proposal for gas station chain Caltex Australia Ltd. (now known as Ampol Ltd.), ending a six-month pursuit. Its largest acquisition to date is Texas-based CST Brands Inc., a rival chain it agreed to buy in 2016 for about $4 billion.
— With assistance by Flavia Krause-Jackson
COVID-19 changed how we work. Will it stick? – CBC.ca
Mexican MVNO Simplii to cease operations on 21 Jan – Telecompaper
One of Canada's oldest seniors, at 110 years old, gets COVID-19 vaccine at Surrey care home – Surrey Now-Leader
Silver investment demand jumped 12% in 2019
Iran anticipates renewed protests amid social media shutdown
Galaxy M31 July 2020 security update brings Glance, a content-driven lockscreen wallpaper service
Economy15 hours ago
Canadian dollar drops, posts weekly decline on greenback short-covering
Health18 hours ago
Two new COVID cases announced in Nova Scotia, Strang says people are lying to contact tracers – Halifax Examiner
News21 hours ago
New COVID-19 modelling shows pandemic resurgence in Canada rapidly worsening – CTV News
Tech4 hours ago
Samsung Galaxy S21 Ultra 5G First Look: No SD, Insane Zoom – Forbes
Economy15 hours ago
Third wave, constrained government spending biggest risks to economy: Poloz – BNN
Health13 hours ago
COVID-19: B.C. health officials report 509 new cases, nine additional deaths – Vancouver Sun
Health15 hours ago
Quebec to wait up to 90 days to give second dose of COVID-19 vaccine – Yahoo News Canada
Tech15 hours ago
ICBC gets green light to slash car insurance by 15% starting in May – Vanderhoof Omineca Express